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Apoptosis is generally regarded as a critical regulatory
event in the development of malignancies in several dif-
ferent organ systems (Thompson, 1995). Initially, oncol-
ogists focused on alterations in rates of proliferation and
cell cycle kinetics, but more recently an emphasis on
apoptosis has dominated the ¢ght against cancer (Evan
and Vousden, 2001). As approximately 1,000,000 indivi-
duals in the U.S.A. develop skin cancer each year, it is
important to elucidate the molecular mechanisms that
govern cell survival and cell death in the epidermis
(Miller andWeinstock, 1994). Moreover, given that most
skin cancers occur on sun-exposed skin, the pro-apop-
totic and antiapoptotic response of keratinocytes (KC)
to UV light is of particular relevance to the develop-
ment of skin cancer (Brash et al, 1996). Whereas both
squamous cell carcinoma (SCC) and basal cell carcino-
ma (BCC) arise from epidermal KC, it is becoming in-
creasingly apparent that the natural history of their
development, their underlying molecular pathogenesis,
and potential involvement of antiapoptotic pathways
are signi¢cantly di¡erent. Nonetheless, as pointed out
later in the text, signi¢cant progress is being made in
our understanding of the pathophysiology of these rela-
tively common epithelial-cell-derived neoplasms. In
this review we will explore four topics: ¢rst, a review
of the life and death signaling pathways operative
in normal human skin that prevents premature apopto-
sis of KC with an emphasis on nuclear factor jB
(NFjB) survival signals; second, the molecular path-
ways that are engaged and regulate apoptosis after nor-
mal KC are exposed to ultraviolet (UV) light; third, the
apoptotic resistant mechanisms that premalignant and
malignant KC utilize to avoid cell death; fourth, thera-
peutic strategies that can render malignant cells more
susceptible to apoptosis with an emphasis on a death
pathway mediated by the death ligand TRAIL. Key
words: Apoptosis/Caspase/Keratinocyte/Squamous cell carci-
noma/Ultraviolet irradiation. JID Symposium Proceedings
7:27 ^35, 2002
LIFE AND DEATH SIGNALING IN NORMAL HUMAN
SKIN AND NORMAL KC
I
ronically, the maintenance of cutaneous homeostasis re-
quires creation of the stratum corneum, which in turn de-
pends on the properly regulated formation and function of
dead KC in the outermost epidermal layers (Fig 1; Qin et al,
2001a). Despite this incredibly thin layer of dead cells, these
corneocytes are extremely e⁄cient at subserving a barrier func-
tion: preventing dehydration and invasion by toxic environmen-
tal agents (Nemes and Steinert, 1999). Due to the unique
anatomical and structural requirements of the epidermis, not only
must it be a self-renewing tissue, but also the ongoing prolifera-
tion must be balanced with KC di¡erentiation and ultimately cell
death. Most importantly, the death of corneocytes must be
delayed until early and late (i.e., terminal) di¡erentiation has
occurred (Weil et al, 1999). We have recently coined the phrase
‘‘planned cell death pathway’’ to emphasize the highly coordi-
nated spatial and temporal reactions in the epidermis that ulti-
mately give rise to corneocytes (Nickolo¡ and Denning, 2001;
Qin et al, 2001a).
Figure 2 portrays the potential contributions of various bio-
chemical pathways involved in regulating cellular reactions in
each discrete epidermal compartment, ultimately leading to cell
death and barrier formation (i.e., corneogenesis). Beginning in
the basal cell layer, the proliferating compartment involving stem
cells/transiently amplifying KC, the cell cycle regulatory mole-
cules are highlighted as being important. Next, the movement
of KC into the suprabasal layer in which early di¡erentiation oc-
curs is accompanied by changes in the cell cycle resulting in
growth arrest, activation of NFkB, with appearance of mediators
that can prevent premature apoptosis by various stimuli including
activation of p53. Examples of antiapoptotic mediators include
cell survival gene products such as Bcl-xL, various decoy recep-
tors, and cell cycle inhibitors (i.e., p21). In addition, we recently
identi¢ed an important role for Notch signaling in the di¡eren-
tiation and corni¢cation process in human epidermis that in-
volved both NFkB and PPAR signaling (Nickolo¡ et al, 2002).
Once late stage and terminal di¡erentiation programs are in-
itiated, it is postulated that speci¢c death e¡ector pathways are
engaged involving death receptors, death ligands, and various cas-
pases. Experimental evidence to support these proposed pathways
is provided below. Before delving into the speci¢cs of the apop-
totic machinery, a brief review of potential life and death media-
tors will be provided.
To maintain a proper homeostatic thickness and function of
the epidermis, KC proliferation and survival must be counterba-
lanced by cell death (Fig 3). A partial listing of molecules that
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promote KC survival is depicted on the left side of Fig 3, whereas
those factors that decrease KC survival are shown on the right
side. As can be appreciated from the rather large and diverse set
of molecules presented, the overall regulation of KC survival and
death is likely to be complex, redundant, and highly coordinated
to ensure that on the one hand there is not premature apoptosis of
KC prior to terminal di¡erentiation, but also on the other hand
not such enhanced longevity of KC that precludes formation of
the stratum corneum (Eckert et al, 1997; Rosenthal et al, 1998; Ishi-
da-Yamamoto et al, 1999). Because cancer may be viewed as a dis-
ease of deregulated survival it is important to delineate which, if
any, of the antiapoptotic factors present in normal KC are also
utilized by malignant cells (Hanahan andWeinberg, 2000).
There is an intense search under way by several laboratories to
elucidate the biochemical mediators that regulate apoptosis in
normal and diseased epidermis as depicted in Figs 2 and 3
(Hakke and Polakowski, 1993; Trefzer et al, 1993; Norris, 1995;
Kothny-Wilkes et al, 1998; Teraki and Shiohara, 1999;Wehrli et al,
2000). Some components of the biochemical machinery that may
contribute to regulating apoptosis in normal human epidermis
are portrayed in Fig 4. By fractionating normal human epidermis
into distinct bands using a Percoll gradient (Rennecke et al, 1999),
whole cell extracts can be produced and examined by Western
blot. The buoyancy of each cell layer can be con¢rmed not only
by cytologic examination of fractions 1^6, but by the matura-
tional state of KC veri¢ed by di¡erential expression of loricrin,
keratin-1, and b4 integrin (Fig 4). Perhaps the most signi¢cant
initial impression of this pro¢le for components of the apoptotic
machinery in normal human skin is the nonrandom spatial dis-
tribution of individual molecules. For example, whereas the
TRAIL death receptor 4 (DR-4) is present in all cell fractions,
the DR-5 becomes more abundant in the upper cell layer frac-
tions. By contrast, the tumor necrosis factor receptor 1 (TNF-
R1) is more conspicuous in the basal layer and mid-epidermal
layers, but decreases in the upper cell layers. The decoy receptor-
2 for TRAIL is detectable in all cell layers, but is enhanced near
the surface whereTRAIL levels tend to be the highest (Nickolo¡,
unpublished observation). The intact or pro-form of caspase 14 is
only transiently detected in fractions 2 and 3, which may support
it as initially being synthesized in the mid-epidermal layers, and
becomes activated (i.e., cleaved) in fraction 1. Caspase 8 appears to
be synthesized in the basal layer and may not be activated until
fraction 3, whereas Bcl-xL levels are relatively constant through-
out all cell layers.
As can be seen by reviewing the aforementioned data, molecu-
lar mediators of KC cell death in human epidermis may include
various death ligands, death receptors, and caspases. Even though
it is currently unclear if di¡erentiation and corni¢cation (includ-
ing apoptosis) share biochemical mediators, the overall molecular
process must be coordinated in such a manner that terminal dif-
ferentiation is completed prior to the onset of apoptosis (Mitra
et al, 1997; Rosenthal et al, 1998; Gandarillas et al, 1999; Takahashi
et al, 2000). As regards death ligands/receptors and intracellular
signaling of apoptosis in KC, members of the TNF family ^ in-
cluding Fas ligand (Fas L) andTRAIL, as well as caspase 14 ^ have
become leading contenders mediating the demise of KC in the
epidermal compartment of normal skin (Sayama et al, 1994; Mat-
sue et al, 1995; Kothny-Wilkes et al, 1998; Van de Craen et al, 1998;
Eckhart et al, 2000; Leverkus et al, 2000; Lippens et al, 2000;
Bachmann et al, 2001; Qin et al, 2001a). Besides these molecular
mediators of cell death, KC also possess intracellular signaling
pathways such as NFkB that can promote KC survival.
The single most important function of skin is:
To produce and maintain an effective barrier
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Figure1. Histologic view of normal human skin highlighting the
spatial coordination of KC proliferation, di¡erentiation, and death
contributing to creation of stratum corneum in the so-called
‘‘planned cell death pathway’’. Ironically, the vitality of skin is depen-
dent on a highly orderly process by which proliferating KC in lower layers
of epidermis (nuclei positively stained for a cell cycle marker ^ Ki67; white
arrows) become growth arrested, undergo terminal di¡erentiation in upper
layers (stratum granulosum), followed by cell death to produce corneocytes
in the outermost layers. Note that even though the stratum corneum is
composed of dead KC, it remains metabolically alive, and is responsible
for the barrier properties of skin.
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Figure 2. Schematic presentation of cellular, biochemical, and apoptotic contributors to the ‘‘planned cell death pathway’’. Note the interplay
of mediators that regulate cell cycle activity, early/late di¡erentiation, and cell survival.
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The survival of normal KC is clearly dependent on NFkB
(Fig 2) as disrupting this signaling pathway either pharmacologi-
cally using the proteosome inhibitor MG132 (Chaturvedi et al,
1999), or by a genetic approach in which retroviral vectors are
constructed with a dominant negative form of IkBa (i.e., Ik
BaDN; Qin et al, 1999), is accompanied by enhanced susceptibil-
ity to apoptosis in vitro. In vivo, disrupting NFkB signaling in
transgenic murine epidermis leads to an increased frequency of
apoptotic KC (Seitz et al, 2000). Furthermore, interfering with
the IKKa component of the NFkB pathway inhibits terminal
di¡erentiation of murine skin (Hu et al, 1999; Li et al, 1999; Takeda
et al, 1999; Makris et al, 2000). As regards susceptibility to apopto-
sis, it appears that NFkB signaling can also regulate levels of de-
coy receptors that normally protect KC against TRAIL-induced
apoptosis (Qin et al, 2001b).When NFkB is disrupted using the
IkBaDN retrovirus, decoy receptor levels are signi¢cantly re-
duced, and exposure of these cells to TRAIL, which normally
are resistant to apoptosis, renders them susceptible to apoptosis.
Besides these newly discovered cell survival pathways mediated
by NFkB, earlier studies uncovered many other antiapoptotic
mechanisms at the disposal of cells that activate the pathway
NFkB (Qin et al, 1999).
During NFkB activation, several subunits such as p50 and p65
form heterodimers and recruit coactivators such as p300 to en-
hance transcription of many antiapoptotic genes (Chaturvedi
et al, 2001). Examples of such NFkB inducible products include
c-IAP1, c-IAP2, TRAF1, TRAF2, etc. (Beg and Baltimore, 1996;
Wang et al, 1998). Of note, in many cell types NFkB activation is
conducive for cell proliferation, but in KC NFkB triggers abrupt
growth arrest ^ presumably via induction of the cyclin-depen-
dent kinase inhibitor, p21 (Seitz et al, 2000). Thus, it should not
be surprising that for premalignant or malignant cells to escape
cell cycle check points on their route to becoming immortalized,
cells such as HaCaTcells possess altered NFkB signaling pathways
(Chaturvedi et al, 2001). As will be discussed later, immortalized
cells that have dampened down or eliminated the NFkB response
may be particularly susceptible to apoptosis because the loss of
cell cycle restraint exacts a toll on the cell ^ namely a diminution
or loss of various cell survival proteins. As can be appreciated
from this brief review, there are many molecular tools at the dis-
posal of normal KC to resist apoptosis, and considerable work re-
mains to better understand how these diverse mediators are
integrated and coordinated to properly balance life and death
events in the epidermis. It should also be mentioned that in some
cell systems activation of NFkB is required for the p53-mediated
apoptotic response (Evan and Vousden, 2001).
RESPONSE OF KC TO UV LIGHT
As sunlight exposure is one of the leading causes of skin cancer, it
is imperative to try to understand how KC respond to UV light
(Godar, 1999). Skin cancer is the most frequently observed neo-
plasm in Caucasians, with a lifetime risk nearly equal to all other
cancers combined (Kraemer, 1997). A hallmark feature of UV ex-
posure in skin are so-called sunburn cells, which represent apop-
totic epidermal KC (Danno and Horio, 1987; Young, 1987).
Previously, the functional role of these apoptotic KC was obscure,
but recent evidence suggests that sunburn cells are not just mar-
kers for severe sun damage, but this apoptotic process is impor-
tant for preventing skin cancer (Brash et al, 1996). A critically
important apoptotic role for the tumor suppressor gene, p53, has
emerged from multiple experimental approaches (Brash et al,
1991; Lehman et al, 1993; Jonason et al, 1996; Aguilar-Lemarroy
et al, 2002; Qin et al, 2002a). These oncologic observations have
triggered signi¢cant interest in de¢ning the apoptotic process in
KC following UV light exposure (Gniadecki et al, 1997; Chatur-
vedi et al, 1999; Shimizu et al, 1999; Denning et al, 2002;
Iordanov et al, 2002; Kim et al, 2002; Murphy et al, 2002).
As illustrated in Fig 5, the response of KC to UV light prob-
ably activates multiple death pathways within the irradiated cell
including: the ability of UV light to multimerize or activate clus-
tering of death receptors (i.e., DR) in the plasma membrane
including Fas and other TNF family members (Devary et al,
1993; Rosette and Karin, 1996; Leverkus et al, 1997a,b; Aragane
et al, 1998; Zhuang et al, 1999); generation of reactive oxygen spe-
cies with mitochondrial release of pro-apoptotic mediators such
as cytochrome C and Apaf-1 (Renzing et al, 1996; Denning et al,
1998; 2001); and DNA damage with p53 activation (Tron et al,
1998; Fisher, 2001). Several transgenic mouse models revealed im-
portant roles for Fas/FasL, as well as Bcl-2/Bcl-x, and p53 in med-
iating sensitivity to UV-induced apoptosis of KC (Pena et al, 1998;
Rodriguez-Villaneuva et al, 1998; Qin et al, 2002b; Hill et al, 1999;
Santamaria et al, 2002). In addition, UV light also activates the
MAP kinase families including extracellular regulated kinase
(ERK), p38, and stress activated protein kinase/c-jun N-terminal
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Figure 4. Apoptotic machinery in normal human skin. By fractio-
nating normal human epidermis according to maturational state into six
fractions, the nonrandom spatial distribution of various molecular compo-
nents of the apoptotic machinery can be appreciated. There are many nat-
ural defense mechanisms that counterbalance the mitogenic activity
inherent in a self-renewing tissue such as the human epidermis. Potentially
important regulators of KC life and death levels include Bcl-xL; caspases 8,
14; TNF-R1; TRAIL ^ decoy and death receptors. b-actin levels are por-
trayed to demonstrate equivalent protein loading for each cell fraction.
Figure 3. Many molecular mediators contribute to the life and
death balance of epidermal KC. The epidermis is not simply a barrier
between external and internal environments, but is the site for numerous
signaling pathways that have life and death consequences. Those factors
that may enhance KC survival are depicted on the left-hand side, and those
factors that decrease KC survival are depicted on the right-hand side. The
precise epidermal layers that contain individual survival and death media-
tors should not be inferred by the location within the triangles, e.g., p63 is
primarily expressed in basal layer KC.
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kinase (JNK) in KC that impacts their survival (Assefa et al, 1997;
Ramaswamy et al, 1998; Peus et al, 1999; Shimizu et al, 1999;
Nakamura et al, 2001). On the £ip side various growth factors
and cytokines including epidermal growth factor, interferon-g
(IFN-g), and interleukin-1 can protect KC against UV-induced
apoptosis (Kothny-Wilkes et al, 1998; Stoll et al, 1998; Qin et al,
1999; Jost et al, 2001).Whereas much has been learned regarding
the decision of whether a KC will undergo apoptosis after UV
irradiation, many molecular mechanistic insights remain to be
determined for this critical process in photo and multistage-epi-
dermal carcinogenesis (Greenhalgh et al, 1996).
To dissect out various potential apoptotic pathways involved in
UV-light-induced apoptosis, several inhibitors have been em-
ployed. To determine if plasma membrane-based death receptors
participate in UV-induced apoptosis, KC were infected with a
retrovirus designed to overexpress a dominant negative form of
FADD (i.e., FADD-DN). As the death receptor complex in the
plasma membrane is coupled to proximal caspases (i.e., caspase
8) by adaptor molecules such as FADD, introducing a dominant
negative version of FADD is a method to identify the apoptotic
contribution of the aforementioned death receptor pathways fol-
lowing various stimuli. After con¢rming overexpression of
FADD-DN, and blocking TRAIL-mediated apoptosis, the apop-
totic response to UV light was examined and found not to be
in£uenced by the overexpression of FADD-DN (Qin et al,
2001a). Also, addition of anti-Fas antibody (100 ng per ml)
did not inhibit UV-induced apoptosis (Denning et al, 2002).
Hence, it does not appear that plasma membrane-based death re-
ceptors play a major role in the UV-light-induced apoptotic path-
way for KC.
Moving to mitochondrial-based components of the apoptotic
machinery, however, several results indicate a signi¢cant partici-
patory role for those mediators in the UV response of KC. If KC
are infected with retroviral constructs designed to overexpress
either Bcl-2 or Bcl-x (which associate with mitochondria), then
the subsequent apoptotic response to UV light is signi¢cantly de-
creased (Qin et al, 2002a,b). Moreover, addition of the protein ki-
nase C (PKC) inhibitor GF 109203x(GF), which can block
mitochondrial-associated PKC-d, also reduces the susceptibility
of KC and HaCaT cells to UV-induced apoptosis (Denning et al,
2001; Sitailo et al, 2002). Finally, employing an inhibitor of free
oxygen radicals that can damage mitochondria, such as pyrroli-
dine dithiocarbamate (PDTC), also reduces the susceptibility of
KC and HaCaTcells to UV-induced apoptosis (Fig 6A, B, respec-
tively). The precise mechanism by which PDTC inhibits apopto-
sis remains to be determined, but is not likely to involve p53
because it can equally protect normal KC as well as HaCaT cells
(which have mutated both p53 alleles), and because there was no
increase in p53 functional activity using a luciferase-based repor-
ter assay or increase in total p53 protein levels (data not shown).
One mechanism by which PDTC inhibits apoptosis in KC is by
reducing the release of cytochrome C from mitochondria
(Fig 6C). Interestingly, whereas PDTC did not increase NFkB
activity, it did increase the antiapoptotic cell-cycle-dependent ki-
nase inhibitor p21 as determined at the mRNA and protein levels
(data not shown).
Perhaps the most well studied molecular determinant of UV-
induced apoptosis is p53, which is regarded as the guardian of the
genome (Levine, 1997). The p53-driven apoptotic response is
termed cellular proofreading in which KC are eliminated rather
than being repaired (Brash et al, 1996). The apoptotic response
of KC to UVB light is dependent in part upon expression and
activation of p53 (Ziegler et al, 1994; Qin et al, 2002a,b). The pre-
cise death e¡ector molecules involved in this pathway remain to
be determined, but evidence using the human papillomavirus
(HPV) derived E6 protein indicates a role for the pro-apoptotic
protein Bak (Jackson and Storey, 2000). Moreover, as certain
strains of HPV are implicated in the development of skin cancer,
the ability of E6 to block Bak-mediated apoptosis has been pos-
tulated as a mechanism by which premalignant and malignant
HPV-infected cells can enhance their survival, thereby promoting
carcinogenesis in skin (Jackson et al, 2000).
Returning to Fig 5, it should be emphasized that there are
multiple pathways by which KC can be triggered to undergo
apoptosis. It is probable that such a wide assortment of pathways
exists to ensure that a KC dies when given an apoptotic signal,
even if one pathway is inactivated. Obviously these multiple
apoptotic pathways have implications for skin cancer develop-
ment, as activation of any one of these distinct pathways could
eliminate a potentially cancerous cell. Although more details will
be provided in the next section, a brief mention of the p53 path-
way is relevant. On the one hand, whereas p53 is frequently
mutated in sun-exposed normal human skin, these cells appar-
ently have little to no precancerous potential (Ponten et al, 1995).
Thus, eliminating such KC via a di¡erent apoptotic mechanism
that is p53-independent is valuable and perhaps best highlighted
by the fact that Li^Fraumeni patients (individuals with germ-line
p53 mutations) do not develop an excess of skin cancers. Such
clinical observations emphasize the importance of further studies
on both preneoplastic and malignant cells in which distinct apop-
totic pathways are dissected and viewed from a therapeutic target-
ing perspective (Ponten et al, 1995; Ananthaswamy et al, 1999;
Stratton et al, 2000; Goukassian et al, 2002). In the next section,
this line of inquiry will be further examined and discussed with
a focus on skin cancers rather than normal epidermis.
MOLECULAR DETERMINANTS OF LIFE OR DEATH
PATHWAYS IN SKIN CANCER
In this section emphasis moves from normal epidermal KC to
cancer cells that comprise SCC and BCC of the skin. Given space
constraints, the focus will be con¢ned to a few important cell
survival pathways mediated by NFkB, Bcl-x, p53, a death path-
way involving TRAIL, and the Hedgehog (Hh) signaling sys-
tem. There is compelling in vitro and in vivo data pointing to a
critically important role for NFkB-mediated signaling events that
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HOW TO KILL A KERATINOCYTE
Figure 5. How to kill a KC.There are at least three di¡erent pathways of
importance in the skin that can contribute to the death of a KC when ex-
posed to UV light. UV light may oligomerize death receptors in the plas-
ma membrane (left-hand side); or UV light may trigger release of
proapoptotic mediators from the mitochondria (center pathway); or UV
light my cause DNA damage and increase p53 activity leading to induction
of Apaf-1 (right-hand side). Following the proximal molecular events
various caspase cascades are set into motion as depicted with cross-talk be-
tween pathways. Ultimately, ¢nal e¡ector caspases are activated,
leading to DNA fragmentation and apoptosis.
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produce a death-defying phenotype to SCC (Du¡ey et al, 1999;
Van Hogerlinden et al, 1999). Experimental protocols in which
NFkB signal transduction is disrupted render the SCC cells sus-
ceptible to apoptosis. As mentioned earlier, several cell survival
pathways are regulated by NFkB. It should be noted that the
NFkB pathway is a bit more complicated than just in£uencing
cell survival, as NFkB activation is also associated with growth
arrest because agents that stimulate NFkB produce enhanced p21
levels (Seitz et al, 2000).The net e¡ect of disrupting NFkB signal-
ing in the epidermis, however, is not only to impact terminal dif-
ferentiation but to promote the appearance of SCC (Kaufman
and Fuchs, 2000).
Immunohistochemical-based investigations of cell survival
pro¢les in skin cancer have revealed overexpression of Bcl-2 and
Bcl-x in BCCs and SCC, respectively (Cerroni and Kerl, 1994;
Morales-Ducret et al, 1995; Rodriquez-Villaneuva et al, 1995;
Wrone-Smith et al, 1999). Surprisingly, many tumor cells, while
displaying increased cell cycle activity using antibodies to detect
either proliferating cell nuclear antigen (PCNA) or Ki67, also ex-
pressed elevated levels of the pro-apoptotic protein Bax along
with the Bcl-2/Bcl-x. As mentioned earlier, abrogation of Bak
expression is associated with skin cancer (Jackson et al, 2000),
and expression of Bak can suppress transformation (Zong et al,
2001).Thus, rather than just focusing on a single cell survival pro-
tein or proliferation marker, it is important to examine the over-
all balance of all life and death determinants (Wrone-Smith et al,
1999).
Transgenic mice in which epidermal KC overexpress the cell
survival proteins Bcl-x or Bcl-2 are more prone to develop var-
ious skin tumors (Pena et al, 1998; Rodriguez-Villaneuva et al,
1998). These in vivo ¢ndings con¢rm the view that skin cancer is
a disease of deregulated survival (Evan and Vousder, 2001); how-
ever, it should be noted that the overexposure of either Bcl-2 or
Bcl-x did not by itself result in skin cancer, but only following
various oncogenic stimuli. Moreover, somewhat unexpectedly
when Bcl-2 was targeted for overexpression by hair follicle
epithelium, there was premature loss of hair, rather than a tricho-
trophic response (Mˇller-R˛ver et al, 2000). Thus, there are still
many unknown biologic processes that remain to be elucidated
concerning the regulation of apoptosis in the epidermis and hair
follicle.
p53 is the most commonly mutated gene identi¢ed in human
cancers (Greenblatt et al, 1994). UV-induced mutation in the p53
gene has been implicated as an important factor for developing
skin cancer, as a reduced susceptibility to apoptosis would favor
survival and clonal expansion of mutated KC (Li et al, 1995; Brash
et al, 1996). The majority of human SCC contain p53 mutations
(Brash et al, 1991), and transgenic mice with p53 mutant alleles
are more susceptible to UV-induced SCC (Li et al, 1995). Another
downstream e¡ector pathway regulated by p53 involves Fas/FasL,
and hence alteration in p53 may confer a death defying pheno-
type by deregulating the Fas/FasL apoptotic pathway as observed
in several types of skin cancer including SCC and melanoma
(Owen-Schaub et al, 1998; Hill et al, 1999). Not only can skin tu-
mor cells fail to express Fas, but they can concomitantly express
FasL, and thereby kill in¢ltrating antitumor T cells that express
Fas (Gutierrez-Steil et al, 1998).
Besides tumor cells down-modulating the death receptor Fas
(CD95), it was recently observed that premalignant KC in actinic
keratoses and malignant cells in SCC also reduce their expression
of the death receptor for TRAIL (Bachmann et al, 2001). More-
over, it appears that the response of normal KC in vivo to UV
irradiation is to reduce levels of TRAIL and its death receptors
(Bachmann et al, 2001). Thus, tumor cells in skin utilize many
strategies to avoid apoptosis.
Finally, before leaving the discussion, it is important to point
out that another signaling pathway is relevant for the develop-
ment of BCC ^ namely the Hh signal transduction pathway
Figure 6. PDTC protects KC and HaCaTcells against UV-induced apoptosis. (A) KC cells; (B) HaCaTcells.Whereas PDTC (10, 50, 100 mM) by itself
had little e¡ect on the viability of KC (left panel) or HaCaT cells (right panel), addition of PDTC for 2 h prior to UV light (25 mJ per cm2) reduced the
number of apoptotic cells in a dose-dependent fashion. Apoptotic cells were measured after 18 h of UV light following incubation with propidium iodide
and cell sorting with sub-G0 DNA content containing cells de¢ned as apoptotic as previously described (Chaturvedi et al, 1999). (C) Western blot analysis
demonstrating release of cytochrome C by mitochondria isolated from KC before (lane 1) and 18 h following UV light (25 mJ per cm2) in the absence
(lane 2) and presence (lane 3) of PDTC (2 h pretreatment; 50 mM). Note the UV-light-induced release of cytochrome C is blocked by PDTC. Equal protein
loading con¢rmed by b-actin levels.
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(Taipale and Beachy, 2001). Even though several groups have
linked genetic alteration in the Hh pathway to BCC, it remains
to be determined which Hh target genes contribute to the
enhanced proliferation and survival of tumor cells in BCC (Hahn
et al, 1996; Oro et al, 1997; Xie et al, 1998; Nilsson et al, 2000). One
report suggests that Hh may oppose epithelial cell arrest (Fan and
Khavari, 1999), but additional molecular mediators are likely to
be involved in the formation and expansion of BCC in sun-ex-
posed skin.
RENDERING MALIGNANT CELLS SUSCEPTIBLE TO
APOPTOSIS
As several cancer therapeutics kill tumor cells by inducing apop-
tosis, cancer cells that resist apoptosis can protect themselves from
such therapeutic agents (Fisher, 1995; Jaattela, 1999). Many groups
have attempted to enhance the e¡ectiveness of various chemother-
apy agents and ionizing radiation by focusing on methods to in-
hibit cell survival signals provided by NFkB (Wang et al, 1996;
1999). Almost immediately after TNF-a was discovered and
cloned, many investigators hoped that TNF-a would be the ‘‘ma-
gic bullet’’ to cure cancer because TNF-a could kill so many dif-
ferent types of tumor cells (Aggarwal et al, 1985; Pennica et al,
1985); however,TNF-a induces hepatocyte apoptosis and thus the
search for alternative death inducing ligands was begun by several
groups (Gores and Kaufmann, 2001). These new searches led to
the identi¢cation by two independent groups of a new TNF
family member referred to asTRAIL (Ashkenazi et al, 1999;Walc-
zak et al, 1999).When two di¡erent preparations of TRAIL were
Table I. Apoptosis Susceptibility of SCC Linesn
Death Ligand/
Stimulus
SCC-9 SCC-13 SCC-25 SCC-25
Linkernn
SCC-25
lkBaDNnn
None 8.1 4.0 3.8 5.3 6.9
Anti-Fas Ab 11.0 6.6 3.5 9.3 14.2
TNF-a 6.0 11.8 3.8 5.7 20.2
LZ-TRAIL 21.4 55.9 5.8 9.6 19.7
IFN-gþTNF-a 14.5 7.0 5.6 7.8 23.9
UV-Light 13.8 71.9 11.0 12.0 35.8
nValues represent % apoptotic cells (determined by Sub-G0 DNA content
using PI/FACS), 18 hrs after exposure to indicated death ligand.ThisTable portrays
representative results from one of 3 independent experiments.
nnThis SCC line was infected with a retrovirus containing either linker alone,
or a cDNA with the DN mutant of kBa; and then treated with the indicated
death ligand.
Figure 7. TRAIL death (TR1,TR2) and decoy receptor (TR3,TR4) cell surface expression before and 24 h after adriamycin (1 mg per ml) exposure in
SCC-25 cells. Semi-con£uent monolayers of KC were exposed to trypsin/ethylenediamine tetraacetic acid to produce a single cell suspension and then
stained to detect cell surface levels of the respective death/decoy receptors. Ten micrograms per ml of each primary monoclonal antibody (obtained from
Immunex) were incubated for 30 min at 41C followed by washing and exposure to a £uorescein isothiocyanate labeled goat antimouse secondary antibody.
After washing, cells were analyzed on an Epics V Flow cytometer (Hialeah, Fl) as previously described (Chaturvedi et al, 1999). Pooled mouse IgG was used
as a negative control antibody. Apoptotic response of SCC-25 cells before and after exposure to either NT-Apo2L/TRAIL or LZ-Apo2L/TRAIL (lower left
panel), or in the presence/absence of adriamycin (lower right panel). The extent of apoptosis was determined as described for Fig 6.
32 NICKOLOFF ETAL JID SYMPOSIUM PROCEEDINGS
examined, including a recombinant, soluble, native-sequence ver-
sion (amino acids 114^281; NT-Apo2L/TRAIL) and a version of
the ligand fused to trimerizing leucine zipper (LZ-Apo2L/
TRAIL), it was observed that NT-Apo2L/TRAIL did not induce
apoptosis of normal KC but could induce apoptosis of HaCaT
cells (Qin et al, 2001a). Interestingly, the LZ-Apo2L/TRAIL could
induce apoptosis in both normal KC and in an immortalized cell
line HaCaT cells (Qin et al, 2001a).
To explore potential therapeutic strategies that could more e¡ec-
tively kill SCCs but spare normal epidermal cells such as KC, sev-
eral SCC cell lines were exposed to various treatment protocols.
The SCC cell lines studied were SCC-9, SCC-13, and SCC-25 (in-
cluding SCC-25 cells infected by a retrovirus containing either lin-
ker alone or IkBaDN). Initially, cells were exposed to a number of
pro-apoptotic stimuli including anti-Fas monoclonal antibody
(CH-11; 100 ng per ml; Upstate Biotechnology, Lake Placid, NY),
TNF-a (103 U per ml), LZ-Apo2L/TRAIL (300 ng per ml), UV
light (30 mJ per cm2), or IFN-g plus TNF-a. As can be seen, vary-
ing levels of apoptosis were induced depending on the stimulus
and the cell type (Table I). Beginning with the SCC-9 cell line, it
was relatively resistant to the apoptotic e¡ects of anti-Fas antibody
treatment or after exposure to TNF-a, IFN-g plus TNF-a, or UV
light; however, it was moderately susceptible to apoptosis triggered
by LZ-Apo2L/TRAIL. By contrast, SCC-13 cells were markedly
susceptible to both LZ-Apo2L/TRAIL and UV light, being rela-
tively resistant to the other indicated death stimuli. As regards
SCC-25 cells, they were relatively resistant to all stimuli except
for a slight increase triggered by UV light. Thus, these cells were
selected to determine if they could be rendered more susceptible to
apoptosis by interfering with their NFkB signaling pathway. In-
deed, whereas infection with a linker only containing retroviral
construct did not consistently change their phenotype, disrupting
NFkB using the IKBaDN-containing retrovirus did render the
SCC-25 cells between two and three times more sensitive to apop-
tosis induced byTNF-a, LZ-Apo2L/TRAIL, or UV light.
Because we had previously identi¢ed a molecular link between
NFkB pathway disruption and diminished TRAIL decoy receptor
expression in normal KC (Qin et al, 2001b), we next determined if
another potential therapeutic strategy for rendering SCC cells
more susceptible to TRAIL could also involve modulation of de-
coy receptor expression. Thus, the response of SCC-25 cells to
adriamycin was studied. Adriamycin was selected because a pre-
vious report demonstrated that adriamycin could sensitize tumor
cells to TRAIL-induced apoptosis (Wu et al, 1997). SCC-25 cells
constitutively expressed both death (TR-1,TR-2) and decoy recep-
tors (TR-3, TR-4) as shown in Fig 7. The presence of the decoy
receptors may explain the resistance of this cell line to both NT-
Apo2L/TRAIL and LZ-Apo2L/TRAIL; however, after exposure
to adriamycin, although the death receptors could still be detected,
there was no detectable cell surface expression for either decoy re-
ceptor (Fig 7, upper right panel). Whereas adriamycin by itself did
not induce apoptosis, the combination of adriamycin plus either
NT-Apo2L/TRAIL or LZ-Apo2L/TRAIL dramatically induced
the apoptotic response. This was somewhat unexpected, because a
previous report suggested that adriamycin sensitized cells to
TRAIL by increasing DR5 (Wu et al, 1997). Furthermore, the abil-
ity of adriamycin to reduce decoy receptors is independent of
NFkB signaling as there is no reduction in NFkB activity (based
on luciferase reporter assays) following exposure to adriamycin,
and because KC infected with the IkBaDN retrovirus (designed
to block NFkB activity) were equally in£uenced by adriamycin as
evidenced by a decrease in decoy receptor expression (data not
shown). Taken together, these results support a novel mechanism
by which adriamycin can in£uence the cell survival phenotype of
SCC cells by reducing levels of expression of decoy receptors.
SUMMARY
Although it is obvious that maintenance of a physiologic epider-
mal thickness and creation of a stratum corneum requires a prop-
erly regulated balance between life and death signaling pathways,
many molecular determinants remain unknown, as do the inter-
relationships amongst various pathways. Moreover, the malignant
cell transformation process in skin clearly involves alterations
and/or abrogation of signaling pathways that impact cell death/
survival, but clear-cut distinctions between physiologic and
pathologic events have yet to be discerned by investigative skin
biologists. Nevertheless, considerable progress in identifying and
dissecting speci¢c components of the biochemical machinery
governing life and death events in epidermis has been made in
the past 5 y. It is likely not only that new advances will aid our
understanding of the mechanisms underlying creation of the stra-
tum corneum, but that such discoveries will also facilitate devel-
opment of tumor-selective death ligands (Ashkenazi, 2002) that
will not trigger premature apoptosis of adjacent normal, nonma-
lignant epidermal cell types. Because the skin is chronically ex-
posed to sunlight, special attention to the interaction between
the new drugs and UV light will be particularly important for
dermatologists as they seek novel therapies to use to combat skin
cancer.
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